Find a Tender · Contract
Transitional Drugs 2
A public procurement published by Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts via Find a Tender.
- —
- Award value
- £11.3m
- Tender value
- 3
- Suppliers
- 3
- Awards
- 2
- Notices
- Contract
- Stage
Overview
Transitional Drugs 2. This is a tender for a list of drugs that are shortly due to lose their patent exclusivity
Key details
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- active
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- £11,310,772
- First published
- 14 Jul 2023
- Last updated
- 15 Dec 2023
Awards
3 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Teva UK Ltd | 00302461 | — | active | — |
| Mercury Pharmaceuticals Ltd | 02619880 | — | active | — |
| Dr Reddy's Laboratories UK Ltd | 01729064 | — | active | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
FAQs about this procurement
Who is the buyer for "Transitional Drugs 2"?
Transitional Drugs 2 is a UK public-sector procurement published by Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts via Find a Tender.
Has "Transitional Drugs 2" been awarded?
Yes — 3 awards are recorded, with a reported total value of £11,310,772. The current lifecycle stage is "Contract".
Which suppliers are involved in "Transitional Drugs 2"?
3 suppliers are linked: Teva UK Ltd, Mercury Pharmaceuticals Ltd, Dr Reddy's Laboratories UK Ltd.
What is "Transitional Drugs 2" worth?
The reported tender value is £11,310,772.
When was "Transitional Drugs 2" published?
It was first published on 14 Jul 2023 and last updated on 15 Dec 2023, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable